Qureos
evoxtherapeutics

evoxtherapeutics

Domain / Industry not specified
LocationUnited States
Company SizeN/A

About Company

Evox Therapeutics is a privately held biotechnology company based in Oxford, UK, focused on developing next-generation genetic medicines for severe neurodegenerative diseases. The company was incorporated in 2016 and is registered as a biotechnology research and experimental development company. Evox's current strategy combines gene editing with exosome-based delivery technology to target diseases of the central nervous system (CNS), particularly conditions where delivering genetic medicines into the brain has historically been difficult. The company's approach is particularly interesting because its technology is designed to help deliver gene-editing medicines to the brain, potentially addressing one of the major challenges in treating neurodegenerative diseases.

© 2026 Qureos. All rights reserved.